GlassScriptPhysician profile
Kimberly T Jones
NPI 1629469564
$869.56
in general payments reported to CMS, 2019-2025
10 companies · $622 in 2025
The $622 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $16.54 · 2023: $58.30 · 2024: $61.88 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $149.97 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.56 | 2025 | |
| Novo Nordisk INC | $118.75 | 2025 | Ozempic |
| Merck Sharp & Dohme LLC | $111.97 | 2025 | Winrevair |
| Alexion Pharmaceuticals, INC. | $110.67 | 2021 | |
| Cvrx, INC. | $103.00 | 2025 | Barostim Neo System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $96.39 | 2023-2024 | Caplyta |
| Abbott Laboratories | $23.79 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abbvie INC. | $16.54 | 2022 | |
| Stryker Corporation | $13.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.